RATIONALE: Asthma prevalence, onset, remission and relapse, and healthcare use have been intensively studied. However, asthma symptom progression through childhood and adolescence has not been well studied, in part due to the challenges in obtaining consistent and robust long-term follow-up data on a large series of subjects with asthma. OBJECTIVES: To use the asthma diary symptom data of the Childhood Asthma Management Program placebo group (5 yr, 418 subjects, and total 564,518 records) to establish sex-specific high-resolution time courses of the natural progression of asthma symptoms through childhood and adolescence. METHODS: We used the asthma diary symptom code as a measure of daily disease severity. Annual records of Tanner stage were used to determine the influence of puberty on severity. A data alignment technique was used to derive 13-year time courses of mean symptoms and mean Tanner stage. MEASUREMENTS AND MAIN RESULTS: Data analyses showed three age- and sex-related phases of asthma symptom progression: Phase 1 (ages 5 and 6 yr)-greater severity in boys; Phase 2 (ages 7 to 9 yr)-no sex difference in severity; and Phase 3 (age 10-17 yr)-greater severity in girls. The continuous decline of symptoms in both sexes stops abruptly at the onset of puberty. CONCLUSIONS: The severity of asthma symptoms varies through childhood and adolescence, and patterns differ by sex. Puberty has a strong influence on symptom progression in both sexes. Progression of symptoms is a distinct aspect of asthma epidemiology.
RATIONALE: Asthma prevalence, onset, remission and relapse, and healthcare use have been intensively studied. However, asthma symptom progression through childhood and adolescence has not been well studied, in part due to the challenges in obtaining consistent and robust long-term follow-up data on a large series of subjects with asthma. OBJECTIVES: To use the asthma diary symptom data of the Childhood Asthma Management Program placebo group (5 yr, 418 subjects, and total 564,518 records) to establish sex-specific high-resolution time courses of the natural progression of asthma symptoms through childhood and adolescence. METHODS: We used the asthma diary symptom code as a measure of daily disease severity. Annual records of Tanner stage were used to determine the influence of puberty on severity. A data alignment technique was used to derive 13-year time courses of mean symptoms and mean Tanner stage. MEASUREMENTS AND MAIN RESULTS: Data analyses showed three age- and sex-related phases of asthma symptom progression: Phase 1 (ages 5 and 6 yr)-greater severity in boys; Phase 2 (ages 7 to 9 yr)-no sex difference in severity; and Phase 3 (age 10-17 yr)-greater severity in girls. The continuous decline of symptoms in both sexes stops abruptly at the onset of puberty. CONCLUSIONS: The severity of asthma symptoms varies through childhood and adolescence, and patterns differ by sex. Puberty has a strong influence on symptom progression in both sexes. Progression of symptoms is a distinct aspect of asthma epidemiology.
Entities:
Keywords:
epidemiology; sex difference; sex dominance
Authors: A Bjerg-Bäcklund; A B Bäcklund; M S Perzanowski; T Platts-Mills; T Sandström; B Lundbäck; E Rönmark Journal: Allergy Date: 2006-05 Impact factor: 13.146
Authors: Linda Ekerljung; Eva Rönmark; Kjell Larsson; Britt-Marie Sundblad; Anders Bjerg; Staffan Ahlstedt; Sven-Erik Dahlén; Bo Lundbäck Journal: Respir Med Date: 2008-08-28 Impact factor: 3.415
Authors: K C Lødrup Carlsen; G Håland; C S Devulapalli; M Munthe-Kaas; M Pettersen; B Granum; M Løvik; K-H Carlsen Journal: Allergy Date: 2006-04 Impact factor: 13.146
Authors: Jacqueline-Yvonne Cephus; Matthew T Stier; Hubaida Fuseini; Jeffrey A Yung; Shinji Toki; Melissa H Bloodworth; Weisong Zhou; Kasia Goleniewska; Jian Zhang; Sarah L Garon; Robert G Hamilton; Vasiliy V Poloshukin; Kelli L Boyd; R Stokes Peebles; Dawn C Newcomb Journal: Cell Rep Date: 2017-11-28 Impact factor: 9.423
Authors: Sze Man Tse; Sheryl L Rifas-Shiman; Brent A Coull; Augusto A Litonjua; Emily Oken; Diane R Gold Journal: J Allergy Clin Immunol Date: 2016-04-27 Impact factor: 10.793
Authors: Jessie P Buckley; Lesliam Quirós-Alcalá; Susan L Teitelbaum; Antonia M Calafat; Mary S Wolff; Stephanie M Engel Journal: Environ Int Date: 2018-03-20 Impact factor: 9.621
Authors: Lisa Maltz; Ethan L Matz; Heather Gordish-Dressman; Dinesh K Pillai; Stephen J Teach; Carlos A Camargo; Monica J Hubal; Simran Behniwal; Guy D Prosper; Nicole Certner; Raman Marwah; Douglas M Mansell; Fisayo Nwachukwu; Risa Lazaroff; Yodit Tsegaye; Robert J Freishtat Journal: Pediatr Pulmonol Date: 2016-01-15